TAGS: Green and Bioplastics
Arkema successfully placed its first ever Green Bond fully dedicated to the financing of its new world-scale plant in Singapore to manufacture 100% bio-based Rilsan® polyamide 11. For a total amount of €300 million, this Green Bond has a maturity of 6 years and an annual coupon of 0.125%. The offering was more than 10 times oversubscribed.
New World-scale Plant for Maximum Efficiency
By offering innovative solutions to its customers, notably in the field of lightweight materials, new energies and
bio-based products, Arkema aims to generate responsible growth contributing to the sustainable development goals defined by the United Nations.
With this unprecedented Green Bond, fully aligned with Arkema’s CSR policy, the Group is financing its new world-scale plant in Singapore, a major innovative and sustainable project at the heart of its organic growth strategy.
This plant, scheduled to come on stream in 2022, is designed with state-of-the-art technology in order to maximize its efficiency and minimize its environmental impact, and will be dedicated to producing 100% bio-based amino 11 monomer and Rilsan®
polyamide 11 from castor oil, a renewable and sustainable feedstock.
Superior Performance in Demanding Applications
Rilsan® polyamide 11 is recognized worldwide for its superior properties and performance in very demanding applications, significantly contributing to the development of sustainable solutions in fast growing sectors, such as mobility and new energy vehicles, 3D printing as well as consumer goods.
"Thanks to this Green Bond, Arkema gives investors the opportunity to contribute to the development of sustainable solutions in specialty materials, and confirms its leadership in terms of sustainability and innovation," Virginie Delcroix, VP Sustainable Development, Arkema.
Arkema’s Green Bond framework is aligned with the ICMA’s Green Bond Principles as set out in a Second Party Opinion provided by Vigeo Eiris, an independent provider ESG ratings agency.
Source: Arkema